Eat Just, a company that applies cutting-edge science and technology to create healthier, more sustainable foods, announced today that its GOOD Meat division has secured $170 million in new funding. With this transaction, GOOD Meat, the world's first-to-market meat made from animal cells instead of slaughtered livestock, becomes a subsidiary of Eat Just, which announced a $200 million fundraise in March.

The latest investment from funds managed by UBS O'Connor, a hedge fund manager within UBS Asset Management, Graphene Ventures, K3 Ventures and others, will be used to increase capacity and accelerate research and development for high-quality, real meat without slaughter. ABG, LLC; BofA Securities, Inc.; Guggenheim Securities and VERSO Capital advised on the transaction.

Eat Just is a food technology company with a mission to build a healthier, safer and more sustainable food system in our lifetimes. The company's expertise, from functionalizing plant proteins to culturing animal cells, is powered by a world-class team of scientists and chefs spanning more than a dozen research disciplines. Eat Just created America's fastest-growing egg brand, which is made entirely of plants, and the world's first-to-market meat made from animal cells instead of slaughtered livestock. The company has been recognized as one of Fast Company's "Most Innovative Companies," Entrepreneur's "100 Brilliant Companies," CNBC's "Disruptor 50" and a World Economic Forum Technology Pioneer. JUST Egg has been named among Popular Science's "100 Greatest Innovations" and Fast Company's "World Changing Ideas" and the history-making debut of GOOD Meat was heralded as one of 2020's top scientific breakthroughs by The Guardian, Vox and WIRED. For more information on JUST Egg, visit https://ju.st. For more information on GOOD Meat, visit http://goodmeat.co.